CClinicalTrials.gg
RecruitingNCT06220825PRoVent-PEDUpdated Feb 7, 2025

PRactice of VENTilation in Critically Ill PEDiatric Patients

An observational study in Critical Illness and Respiratory Failure, sponsored by University Medical Center Groningen. Recruiting at 1 site in Netherlands. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2025-02-07.

Sponsored by University Medical Center Groningen · Observational

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,500
Ages
Up to 18 Years
Sex
All
01

Study summary

The goal of this worldwide observational study is to investigate ventilation practice in critically ill pediatric patients. The main questions it aims to answer are:

  1. What is the global current practice of ventilatory support in critically ill pediatric patients?
  2. Which potentially modifiable factors related to ventilation are associated with outcome? Participating pediatric intensive care units will gather detailed information about ventilation practice and outcome, such as duration of ventilatory support, length of ICU stay and ICU mortality.
Read the detailed description

Rationale:

Studies on ventilatory support in critically ill pediatric patients remain scarce and much of the current clinical practice is based upon experience and data originating from critically ill adult patients.

Objectives:

  1. To describe the worldwide practice of ventilatory support in critically ill pediatric patients; and
  2. To identify potentially modifiable ventilation parameters that have independent associations with outcome.

Hypothesis:

  1. Practice of ventilatory support in critically ill pediatric patients varies substantially worldwide; and
  2. Potentially modifiable factors related to ventilation have independent associations with outcome in critically ill pediatric patients.

Study design:

International, multicenter, observational cohort study in critically ill pediatric patients. Each year, data will be collected in two predefined 4-week periods, one in the winter season and one in the summer season. A third 4-week period will be in case of epi- or pandemics. The study is designed to run for 10 years; within these 10 years, there will be subprojects during pre-defined periods. Centers have the option to opt out during certain time periods to make the study manageable for every participating country/center.

Study population:

Critically ill pediatric patients (aged 0-18) admitted to the pediatric intensive care unit (PICU) and necessitating ventilatory support > 12 hours. Premature infants will be excluded. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Because of the observational design of the study using routinely collected data, there is no additional burden for the patient. Collection of data from ICU charts or electronic medical records systems is of no risk to the patients.

02

Conditions studied

  • Critical Illness
  • Respiratory Failure

Keywords

  • Ventilation practice
  • Critically ill children
  • PARDS
  • Mechanical ventilation
03

In context

Respiratory Insufficiency

1,650 studies on the registry are indexed under Respiratory Insufficiency; 296 are open to participants now.

This study's planned enrollment of 2,500 is above the median of 100 across 545 observational studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

University Medical Center Groningen is the lead sponsor of 609 studies on the registry; 174 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Critically ill pediatric patients

Inclusion criteria

  • Expected use of (non-)invasive respiratory support for at least 12 hrs

Exclusion criteria

Exclusion Criteria:

  • premature infants (i.e., postconceptional age corrected for gestational age \< 40 weeks)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,500 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Tidal volume

    Tidal volume

    Time frame: First four days of (non-)invasive respiratory support

  2. Peak inspiratory pressure

    Peak inspiratory pressure

    Time frame: First four days of (non-)invasive respiratory support

  3. Plateau pressure

    Pateau pressure

    Time frame: First four days of (non-)invasive respiratory support

  4. Positive end-expiratory pressure

    Positive end-expiratory pressure

    Time frame: First four days of (non-)invasive respiratory support

  5. Driving pressure

    Driving pressure

    Time frame: First four days of (non-)invasive respiratory support

  6. Mechanical power

    Mechanical power

    Time frame: First four days of (non-)invasive respiratory support

Secondary outcomes

  1. PARDS prevalence

    Prevalence of PARDS per PALICC-2 definition

    Time frame: First four days of (non-)invasive respiratory support

  2. Duration of respiratory support (in days)

    Duration of respiratory support (in days)

    Time frame: Up to 28 days following initiation of (non-)invasive respiratory support

  3. Ventilator-free days at day 28

    Ventilator-free days at day 28

    Time frame: Up to 28 days following initiation of (non-)invasive respiratory support

  4. Length of ICU stay (in days)

    Length of ICU stay (in days)

    Time frame: PICU admission

  5. ICU mortality

    ICU mortality

    Time frame: Up to 28 days following initiation of (non-)invasive respiratory support

Other outcomes

  1. Type of ventilatory support

    Type of ventilatory support

    Time frame: First four days of (non-)invasive respiratory support

  2. Type of ventilator mode

    Ventilator mode

    Time frame: First four days of (non-)invasive respiratory support

  3. Use of sedative and/or analgesic drugs (yes/no)

    Use of sedative and/or analgesic drugs

    Time frame: First four days of (non-)invasive respiratory support

  4. Use of neuromuscular blocking agents (yes/no)

    Use of neuromuscular blocking agents

    Time frame: First four days of (non-)invasive respiratory support

  5. Use of vasoactive infusions (yes/no)

    Use of vasoactive infusions

    Time frame: First four days of (non-)invasive respiratory support

  6. Use of prone positioning (yes/no)

    Use of prone positioning

    Time frame: First four days of (non-)invasive respiratory support

  7. Use of ECMO (yes/no)

    Use of ECMO

    Time frame: First four days of (non-)invasive respiratory support

07

Study locations

1 of 1 sites recruiting
  • UMC Groningen
    Groningen, Netherlands
    • Martin CJ Kneyber · Contact · 0031503614215
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Sap

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06220825
Lead sponsor
University Medical Center Groningen
Collaborators
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Responsible party
Sponsor
First posted
Jan 24, 2024
Start date
Apr 1, 2024
Primary completion
Apr 1, 2034 (estimated)
Completion
Apr 1, 2034 (estimated)
Last update
Feb 7, 2025

Study contacts

Relin Van Vliet, MSc
Contact
r.vanvliet@amsterdamumc.nl
0031627560257
David MP van Meenen, MD PhD
Contact
d.m.vanmeenen@amsterdamumc.nl
Martin CJ Kneyber, MD PhD
principal investigator · University Medical Center Groningen
Marcus J Schultz, MD PhD
principal investigator · Amsterdam UMC
Frederique Paulus, RN PhD
principal investigator · Amsterdam UMC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion